Olga Vasiljeva

Publication Activity (10 Years)

Years Active: 2018-2023
Publications (10 Years): 9

Top Topics

Metal Organic Framework

Top Venues

Clinical cancer research : an official journal of the American Association for Cancer Research

Proceedings of the National Academy of Sciences of the United States of America

Cancer research

This page only lists publications with an associated author ORCID identifier.

Publications

Andreja Kozak, Georgy Mikhaylov, Pavlo Khodakivskyi, Elena Goun, Boris Turk, Olga Vasiljeva
A New Cathepsin D Targeting Drug Delivery System Based on Immunoliposomes Functionalized with Lipidated Pepstatin A. Pharmaceutics 15 (10) (2023)
Valentina Boni, Mary J Fidler, Hendrik-Tobias Arkenau, Alexander Spira, Funda Meric-Bernstam, Nataliya Uboha, Rachel E Sanborn, Randy F Sweis, Patricia LoRusso, Misako Nagasaka, Javier García Corbacho, Shadia Jalal, James J Harding, Stella K Kim, Iris H C Miedema, Danielle J Vugts, Marc C Huisman, Gerben J C Zwezerijnen, Guus A M S van Dongen, Catharina Willemien Menke-van der Houven van Oordt, Song Wang, Tam Dang, Ivan A Zein, Olga Vasiljeva, Susan K Lyman, Virginia Paton, Alison Hannah, Joyce F Liu
Praluzatamab Ravtansine, a CD166-Targeting Antibody-Drug Conjugate, in Patients with Advanced Solid Tumors: An Open-Label Phase I/II Trial. Clinical cancer research : an official journal of the American Association for Cancer Research 28 (10) (2022)
Shweta Singh, Laura Serwer, Amy DuPage, Kristi Elkins, Niharika Chauhan, Matthew Ravn, Fritz Buchanan, Leyu Wang, Michael Krimm, Ken Wong, Jason Sagert, Kimberly Tipton, Stephen J Moore, Yuanhui Huang, Andrew Jang, Eric Ureno, Adam Miller, Sarah Patrick, Shanti Duvur, Shouchun Liu, Olga Vasiljeva, Yingchun Li, Tracy Henriques, Ilaria Badagnani, Shawn Jeffries, Siew Schleyer, Rob Leanna, Claus Krebber, Sridhar Viswanathan, Luc Desnoyers, Jonathan Terrett, Marcia Belvin, Susan E Morgan-Lappe, W Michael Kavanaugh, Jennifer Richardson
Nonclinical Efficacy and Safety of CX-2029, an Anti-CD71 Probody-Drug Conjugate. Molecular cancer therapeutics 21 (8) (2022)
Leila M Boustany, Sherry L LaPorte, Laurie Wong, Clayton White, Veena Vinod, Joel Shen, Wendy Yu, David Koditek, Michael B Winter, Stephen J Moore, Li Mei, Linnea Diep, Yuanhui Huang, Shouchun Liu, Olga Vasiljeva, Jim West, Jennifer Richardson, Bryan Irving, Marcia Belvin, W Michael Kavanaugh
A Probody T Cell-Engaging Bispecific Antibody Targeting EGFR and CD3 Inhibits Colon Cancer Growth with Limited Toxicity. Cancer research 82 (22) (2022)
Laura Kist de Ruijter, Jahlisa S Hooiveld-Noeken, Danique Giesen, Marjolijn N Lub-de Hooge, Iris C Kok, Adrienne H Brouwers, Sjoerd G Elias, Margaret T L Nguyen, Hong Lu, Jourik A Gietema, Mathilde Jalving, Derk J A de Groot, Olga Vasiljeva, Elisabeth G E de Vries
First-in-Human Study of the Biodistribution and Pharmacokinetics of 89Zr-CX-072, a Novel Immunopet Tracer Based on an Anti-PD-L1 Probody. Clinical cancer research : an official journal of the American Association for Cancer Research (2021)
Iñaki Etxeberría, Elixabet Bolaños, Alvaro Teijeira, Saray Garasa, Alba Yanguas, Arantza Azpilikueta, William M Kavanaugh, Olga Vasiljeva, Marcia Belvin, Bruce Howng, Bryan Irving, Kimberly Tipton, James West, Li Mei, Alan J Korman, Emanuela Sega, Irene Olivera, Assunta Cirella, María Carmen Ochoa, Maria E Rodríguez-Ruiz, Ana Melero, Miguel F Sanmamed, John J Engelhardt, Ignacio Melero Bermejo
Antitumor efficacy and reduced toxicity using an anti-CD137 Probody therapeutic. Proceedings of the National Academy of Sciences of the United States of America 118 (26) (2021)
Hikmat H Assi, Chihunt Wong, Kimberly A Tipton, Li Mei, Ken Wong, Jennifer Razo, Chanty Chan, Bruce Howng, Jason Sagert, Michael Krimm, Linnea Diep, Andrew Jang, Margaret T Nguyen, Nicole Lapuyade, Victoria Singson, Ruth Villanueva, Madan Paidhungat, Shouchun Liu, Vangipuram Rangan, Olga Vasiljeva, James W West, Jennifer H Richardson, Bryan Irving, Dylan Daniel, Marcia Belvin, W Michael Kavanaugh
Conditional PD-1/PD-L1 Probody Therapeutics Induce Comparable Antitumor Immunity but Reduced Systemic Toxicity Compared with Traditional Anti-PD-1/PD-L1 Agents. Cancer immunology research 9 (12) (2021)
Danique Giesen, Linda N Broer, Marjolijn N Lub-de Hooge, Irina Popova, Bruce Howng, Margaret T Nguyen, Olga Vasiljeva, Elisabeth G E de Vries, Martin Pool
Probody Therapeutic Design of 89Zr-CX-072 Promotes Accumulation in PD-L1-Expressing Tumors Compared to Normal Murine Lymphoid Tissue. Clinical cancer research : an official journal of the American Association for Cancer Research 26 (15) (2020)
Marat I Lerner, Georgy Mikhaylov, Alexey A Tsukanov, Aleksandr S Lozhkomoev, Elazar Gutmanas, Irena Gotman, Andreja Bratovs, Vito Turk, Boris Turk, Sergey G Psakhye, Olga Vasiljeva
Crumpled Aluminum Hydroxide Nanostructures as a Microenvironment Dysregulation Agent for Cancer Treatment. Nano letters 18 (9) (2018)